CVE-2018-14789
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and…
Does this matter?
Lower severity and a low EPSS score (0.45%). Track it; it rarely justifies an emergency change on its own.
Description
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.
- CVSS 3.1
- 6.7 MEDIUMCVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.45% probability · 39th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-428
- Affected
- philips/intellispace cardiovascular · philips/xcelera
- Source
- ics-cert@hq.dhs.gov
EPSS 0.4% since 27 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01Third Party Advisory, US Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-securityVendor Advisory
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01Third Party Advisory, US Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-securityVendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.